Literature DB >> 6454324

Cyclic variation of plasminogen activation in human uterine fluid and the influence of an intrauterine device.

B Casslén, K Ohlsson.   

Abstract

Activation of plasminogen to plasmin in uterine fluid results in the formation of plasmin-alpha 2-antiplasmin complexes. The degree of plasminogen activation was studied during the menstrual cycle in IUD-users and nonusers. The absence of free plasminogen in the presence of plasmin complexes indicated complete activation of the zymogen. The simultaneous occurrence of free plasminogen and plasmin complexes were interpreted to represent incomplete activation. Results were correlated with the concentration of alpha 2-antiplasmin, a major inhibitor of urokinase and plasmin. In the midcycle phase of IUD-non-users, plasminogen activation was complete and the concentration of alpha 2-antiplasmin was low. In the luteal phase of the same population the concentration of alpha 2-antiplasmin was high and there was no plasminogen activation. In contrast, IUD-users generally had an incomplete activation of plasminogen throughout the menstrual cycle. Also, their concentrations of alpha 2-antiplasmin were increased in the proliferative and midcycle phases.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6454324

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  3 in total

1.  Optimization of lentiviral transduction parameters and its application for CRISPR-based secretome modification of human endometrial mesenchymal stem cells.

Authors:  Pavel Deryabin; Anastasiia Griukova; Alla Shatrova; Alexey Petukhov; Nikolay Nikolsky; Aleksandra Borodkina
Journal:  Cell Cycle       Date:  2019-03-28       Impact factor: 4.534

2.  Altered formation of the iron oxide nanoparticle-biocorona due to individual variability and exercise.

Authors:  Lisa M Kobos; Sherleen Xue-Fu Adamson; Sheelagh Evans; Timothy P Gavin; Jonathan H Shannahan
Journal:  Environ Toxicol Pharmacol       Date:  2018-07-29       Impact factor: 4.860

3.  Periodicity in the levels of serum plasminogen activator inhibitor-1 is a robust prognostic factor for embryo implantation and clinical pregnancy in ongoing IVF cycles.

Authors:  Bindu N Mehta; Nirmalendu Nath; Natachandra Chimote
Journal:  J Hum Reprod Sci       Date:  2014-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.